OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Kristine Yaffe

2 Projects | 1 Researchers | $343,515 Invested

2025

University of California - San Francisco

Kristine Yaffe, MD

Long-term follow-up of the Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT)

  • Funding Amount: $243,515
  • Organization Type:
  • Program: Prevention
  • Target: Other
  • Status: Active

2017

University of California - San Francisco

Kristine Yaffe, MD

Connection Between Depressive Symptoms and Dementia: When Best to Intervene.

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Prevention
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed